A high-fat and cholesterol diet causes fatty liver in guinea pigs. The role of iron and oxidative damage

被引:23
作者
Ye, P. [1 ]
Cheah, I. K. [1 ]
Halliwell, B. [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore
关键词
non-alcoholic fatty liver disease; cholesterol; dietary supplementation; iron metabolism; lipid peroxidation; GAMMA-GLUTAMYL-TRANSPEPTIDASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC IRON; HEREDITARY HEMOCHROMATOSIS; LIPID-PEROXIDATION; INSULIN-RESISTANCE; DISEASE; HEPCIDIN; INFLAMMATION; FIBROSIS;
D O I
10.3109/10715762.2013.806796
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease. Iron, cholesterol, and oxidative damage are frequently suggested to be related to the progression of NAFLD, but the precise relationship between them remains unclear. Guinea pigs fed on a high cholesterol and fat diet (without oxidized lipids) generated a disease model of NAFLD with hallmark observations in liver histology and increased liver damage markers. Hepatic cholesterol and iron levels were found to be significantly elevated and directly correlated. Plasma hepcidin and transferrin levels were decreased. Plasma iron concentrations were found to be elevated, likely due to an increased intestinal iron absorption caused by the decrease in plasma hepcidin. However, hepatic transferrin receptor-2 levels were unchanged. No significant increase in hepatic lipid peroxidation was detected using F-2-isoprostanes as a reliable biomarker, nor was there a rise in protein carbonyls, a general index of oxidative protein damage. Some increases in cholesterol oxidation products were observed, but largely negated after normalizing for the elevated hepatic cholesterol content. Indeed, increased hemosiderin deposition and unchanged ferritin levels in liver suggested that the excess iron mainly existed as hemosiderin, which is redox-inactive.
引用
收藏
页码:602 / 613
页数:12
相关论文
共 47 条
[1]   Pathways underlying iron accumulation in human nonalcoholic fatty liver disease [J].
Aigner, Elmar ;
Theurl, Igor ;
Theurl, Milan ;
Lederer, Dieter ;
Haufe, Heike ;
Dietze, Otto ;
Strasser, Michael ;
Datz, Christian ;
Weiss, Guenter .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (05) :1374-1383
[2]   Closing the Iron Gate [J].
Andrews, Nancy C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :376-377
[3]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[4]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[5]  
Bothwell TH, 1998, SEMIN HEMATOL, V35, P55
[6]   Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease [J].
Bridle, KR ;
Cheung, TK ;
Murphy, TL ;
Walters, MM ;
Anderson, GJ ;
Crawford, DHG ;
Fletcher, LM .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (01) :106-112
[7]   Relative contribution of iron burden, HFE mutation and insulin resistance to fibrosis in nonalcoholic fatty liver [J].
Bugianesi, E ;
Manzini, P ;
D'Antico, S ;
Vanni, E ;
Longo, F ;
Leone, N ;
Massarenti, P ;
Piga, A ;
Marchesini, G ;
Rizzetto, M .
HEPATOLOGY, 2004, 39 (01) :179-187
[8]  
Chevion M, 2000, FREE RADICAL RES, V33, pS99
[9]   CHOLESTEROL METABOLISM .3. CHOLESTEROL METABOLISM IN THE GUINEA PIG AND RABBIT [J].
COOK, RP ;
THOMSON, RO .
BIOCHEMICAL JOURNAL, 1951, 49 (01) :72-77
[10]  
DAVIS RJ, 1986, J BIOL CHEM, V261, P8708